FGF21 and obesity disorder: Kim et al. [352] demonstrated that FGF21 deficiency exacerbated obesity-induced inflammation and atrophic responses in skeletal muscle of obese mice, and FGF21 treatment protected against inflammation-induced atrophy via the AMPK pathway.